HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dominik Richard Selected Research

Naproxen (Naprosyn)

7/2007Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dominik Richard Research Topics

Disease

3Pain (Aches)
11/2012 - 10/2010
3Gouty Arthritis
11/2012 - 10/2010
3Osteoarthritis
08/2008 - 01/2006
2Inflammation (Inflammations)
11/2012 - 03/2011
2Ulcer
07/2007 - 01/2006
1Pulmonary Hypertension
10/2017
1Pulmonary Arterial Hypertension
10/2017
1Infections
11/2012
1Hypertension (High Blood Pressure)
08/2008
1Arthritis (Polyarthritis)
07/2007
1Rheumatoid Arthritis
01/2006

Drug/Important Bio-Agent (IBA)

3canakinumabFDA Link
11/2012 - 10/2010
3ColchicineFDA LinkGeneric
11/2012 - 10/2010
3lumiracoxib (prexige)IBA
08/2008 - 01/2006
3Ibuprofen (Motrin)FDA LinkGeneric
08/2008 - 01/2006
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
03/2011 - 10/2010
2Monoclonal AntibodiesIBA
03/2011 - 10/2010
1macitentanIBA
10/2017
1ORALIT (ORS)IBA
11/2012
1Antihypertensive Agents (Antihypertensives)IBA
08/2008
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2007
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2007
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2007
1Naproxen (Naprosyn)FDA LinkGeneric
07/2007

Therapy/Procedure

2Contraindications
03/2011 - 10/2010
1Aftercare (After-Treatment)
10/2010